Used in research and development of therapies targeting Alzheimer’s disease by specifically binding to amyloid beta peptides, helping to clear or neutralize amyloid plaques in the brain. Widely utilized in preclinical studies to evaluate efficacy, pharmacokinetics, and target engagement of anti-amyloid treatments. Serves as a reference standard in immunoassays and imaging techniques to measure amyloid burden and monitor therapeutic response. Supports validation of new antibodies and drug candidates in neurodegenerative disease models.